Rick Doblin

Rick Doblin is an American psychotherapist, researcher, and the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS). He is a prominent figure in the field of psychedelic therapy and psychedelic research, advocating for the medical and therapeutic uses of substances such as MDMA, LSD, psilocybin, and marijuana.

Early Life and Education[edit | edit source]

Doblin was born in 1953. He completed his undergraduate studies at New College of Florida and later earned a doctorate in Public Policy from Harvard University's Kennedy School of Government. His doctoral thesis focused on the medical use of psychedelic drugs.

Career[edit | edit source]

In 1986, Doblin founded the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization that aims to raise awareness and understanding of psychedelic substances. MAPS conducts research into the safety and efficacy of psychedelics for treating various mental health conditions, including post-traumatic stress disorder (PTSD), anxiety, and depression.

Doblin's work with MAPS has been instrumental in advancing the field of psychedelic therapy. He has been involved in numerous clinical trials investigating the therapeutic potential of substances such as MDMA for PTSD and psilocybin for end-of-life anxiety.

Advocacy[edit | edit source]

Doblin is a vocal advocate for the reclassification of psychedelic substances, arguing that they have significant therapeutic potential that is currently underutilized due to legal restrictions. He has testified before the United States Congress and appeared in numerous media outlets to discuss the potential benefits of psychedelic therapy.

Personal Life[edit | edit source]

Doblin is known for his personal use of psychedelics and his belief in their potential to enhance personal growth and self-understanding. He has spoken publicly about his experiences with these substances and their impact on his life and work.

References[edit | edit source]

External Links[edit | edit source]

Multidisciplinary Association for Psychedelic Studies (MAPS)

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.